Treatment of human breast cancer cells with nitric oxide mimetics prevents acquisition of hypoxia-induced resistance to doxorubicin. Proceedings of the American Association for Cancer Research Annual Meeting 42: 814-815, March, 2001
The role of nitric-oxide-synthase-derived nitric oxide in multicellular traits of Bacillus subtilis 3610: biofilm formation, swarming, and dispersal. Bmc Microbiology 11(): 111-111, 2011
Statins revert doxorubicin resistance via nitric oxide in malignant mesothelioma. International Journal of Cancer 119(1): 17-27, 2006
Gastric mucosal injury is amplified by inhibition of nitric oxide synthase activity and attenuated by nitric oxide. Gastroenterology 108(4 SUPPL ): A199, 1995
Impaired learning in rats in a 14-unit T-maze by 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, is attenuated by the nitric oxide donor, molsidomine. European Journal Of Pharmacology. 341(1): 17-22,. 2, 1998
Nitric oxide and Coxsackievirus B3 myocarditis: Differential expression of inducible nitric oxide synthase in mouse heart after infection with virulent or attenuated virus. Journal of Medical Virology 64(2): 175-182, June, 2001
Differential effects of doxorubicin and docetaxel on nitric oxide production and inducible nitric oxide synthase expression in MCF-7 human breast cancer cells. Oncology Research 14(7-8): 381-386, 2004
Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells. Breast Cancer Research and Treatment 96(2): 169-176, 2005
Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux. Cancer Research 65(2): 516-525, 2005
Nitric oxide releasing acridone carboxamide derivatives as reverters of doxorubicin resistance in MCF7/Dx cancer cells. Bioorganic Chemistry 64: 51-58, 2015
Induction of transient resistance to doxorubicin in tumor cells exposed to nitric oxide secreted by activated macrophages. Proceedings of the American Association for Cancer Research Annual Meeting 33: 423, 1992
Treatment of doxorubicin-resistant MCF7/Dx cells with nitric oxide causes histone glutathionylation and reversal of drug resistance. Biochemical Journal 440(2): 175-183, 2012